Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 23 hours agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 2 weeks agoIn a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold a...
Moderna pauses Kenya plant plans as COVID vaccine demand wanes
Reuters via Yahoo News· 2 weeks agoThe move is in line with Moderna's strategy of resizing its manufacturing network to cut costs, even...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown - ...
Benzinga· 15 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 1 day agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Moderna Investors Should Beware Patent-Dispute Fallout (NASDAQ:ABUS)
Seeking Alpha· 15 hours agoModerna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
Zacks via Yahoo Finance· 2 weeks agoData from an early-stage study shows that treatment with Moderna's (MRNA) experimental cancer...
1 New Green Flag for Moderna and Merck Stock
Motley Fool via Yahoo Finance· 2 weeks agoAccording to some new data revealed by Moderna (NASDAQ: MRNA) at the American Association for Cancer Research Annual Meeting on April 8, the biotech...
Moderna paused its plans for a facility in Kenya because COVID-19 vaccine demand has plummeted
Quartz· 2 weeks agoModerna said Thursday that it is pausing its plans to build an mRNA vaccine manufacturing facility...
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
Fortune via AOL· 7 days agoBrad Miller is helping Moderna shift from its reliance on COVID vaccines, with the company hoping to...